Related content

Comparative gene expression profile of p185 Bcr-Abl versus p210 Bcr-Abl expressing cells

By Tipping A.J.   Melo J.V.  

Leukemia Research, Vol. 28, Iss. 3, 2004-03 ,pp. : 219-220

Elsevier

Access to resources Recommend Favorite

Morpholino Oligo Antisense efficiently suppresses BCR/ABL and cell proliferation in CML: specific inhibition of BCR-ABL gene expression by Morpholino Oligo Antisense in BCR-ABL⁺ cells

By Haririan Mahmoud   Kaviani Saeid   Soleimani Masoud   Ghaemi Soraya Rasi   Delalat Bahman   Atashi Amir  

Hematology, Vol. 17, Iss. 1, 2012-01 ,pp. : 28-34

Maney Publishing

Access to resources Recommend Favorite

p210 BCR/ABL1 as a secondary change in a patient with acute myelomonocytic leukemia (M4Eo) with inv(16)

By Dai Hai-ping  

International Journal of Hematology, Vol. 96, Iss. 6, 2012-12 ,pp. : 814-817

Springer Publishing Company

Access to resources Recommend Favorite

BCR/ABL1 Fusion Transcripts Generated from Alternative Splicing: Implications for Future Targeted Therapies in Ph+ Leukaemias

By  

Current Molecular Medicine, Vol. 12, Iss. 5, 2012-06 ,pp. : 547-565

Bentham Science Publishers

Access to resources Recommend Favorite

Differences between in Vivo and in Vitro Sensitivity to Imatinib of Bcr/Abl+ Cells Obtained from Leukemic Patients

By Gambacorti-Passerini C.B.   Rossi F.   Verga M.   Ruchatz H.   Gunby R.   Frapolli R.   Zucchetti M.   Scapozza L.   Bungaro S.   Tornaghi L.   Rossi F.   Pioltelli P.   Pogliani E.   D'Incalci M.   Corneo G.  

Blood Cells, Molecules, and Diseases, Vol. 28, Iss. 3, 2002-03 ,pp. : 361-372

Academic Press

Access to resources Recommend Favorite